CD40 is a prognostic marker in primary cutaneous malignant melanoma.
about
Autoimmunity and the immunotherapy of cancer: targeting the "self" to destroy the "other".Enhancing antitumor efficacy of chimeric antigen receptor T cells through constitutive CD40L expression.T lymphocytes induce endothelial cell matrix metalloproteinase expression by a CD40L-dependent mechanism: implications for tubule formation.Symmetry Controlled, Genetic Presentation of Bioactive Proteins on the P22 Virus-like Particle Using an External Decoration Protein.Immunostimulatory AdCD40L gene therapy combined with low-dose cyclophosphamide in metastatic melanoma patientsSurface antigen profiles of leukocytes and melanoma cells in lymph node metastases are associated with survival in AJCC stage III melanoma patients.Annexin VII as a novel marker for invasive phenotype of malignant melanoma.The CD40/CD40L axis in glioma progression and therapy.
P2860
Q34276512-280D51BB-1B3D-475A-87E5-F7C5C5373CD8Q35399334-9F452339-5B36-45E6-9A10-441765328B0AQ35754623-B7A44761-D54E-4236-AD20-9A74E3AB3E12Q36892485-0462A0CC-4416-447A-9DAA-C47B604483B5Q37174695-2F8D3463-CAA5-4A48-9516-26F7AB481C67Q37681488-C5D758AF-C578-49EB-957C-32571817FED6Q40890223-B6CA5A5D-5D23-4547-B1BA-5823FF2572C2Q43170417-66ABC074-E272-461B-BC29-0F6D7B721439
P2860
CD40 is a prognostic marker in primary cutaneous malignant melanoma.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
CD40 is a prognostic marker in primary cutaneous malignant melanoma.
@ast
CD40 is a prognostic marker in primary cutaneous malignant melanoma.
@en
type
label
CD40 is a prognostic marker in primary cutaneous malignant melanoma.
@ast
CD40 is a prognostic marker in primary cutaneous malignant melanoma.
@en
prefLabel
CD40 is a prognostic marker in primary cutaneous malignant melanoma.
@ast
CD40 is a prognostic marker in primary cutaneous malignant melanoma.
@en
P2093
P2860
P1476
CD40 is a prognostic marker in primary cutaneous malignant melanoma
@en
P2093
Battocchio S
De Wever I
De Wolf-Peeters C
van den Oord JJ
P2860
P304
P407
P50
P577
1996-12-01T00:00:00Z